Cardlytics (NASDAQ:CDLX – Get Free Report) and LiveRamp (NYSE:RAMP – Get Free Report) are both small-cap business services companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, risk, earnings and dividends.
Earnings and Valuation
This table compares Cardlytics and LiveRamp”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Cardlytics | $278.30 million | 0.20 | -$189.30 million | ($2.11) | -0.49 |
| LiveRamp | $745.58 million | 2.12 | -$810,000.00 | $0.61 | 40.75 |
Institutional & Insider Ownership
68.1% of Cardlytics shares are held by institutional investors. Comparatively, 93.8% of LiveRamp shares are held by institutional investors. 4.4% of Cardlytics shares are held by insiders. Comparatively, 3.3% of LiveRamp shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares Cardlytics and LiveRamp’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Cardlytics | -44.12% | -235.70% | -31.31% |
| LiveRamp | 5.15% | 4.44% | 3.38% |
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Cardlytics and LiveRamp, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Cardlytics | 1 | 3 | 0 | 0 | 1.75 |
| LiveRamp | 1 | 4 | 2 | 0 | 2.14 |
Cardlytics presently has a consensus target price of $2.25, suggesting a potential upside of 118.45%. LiveRamp has a consensus target price of $43.50, suggesting a potential upside of 74.98%. Given Cardlytics’ higher probable upside, analysts clearly believe Cardlytics is more favorable than LiveRamp.
Volatility & Risk
Cardlytics has a beta of 1.05, suggesting that its share price is 5% more volatile than the S&P 500. Comparatively, LiveRamp has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500.
Summary
LiveRamp beats Cardlytics on 12 of the 14 factors compared between the two stocks.
About Cardlytics
Cardlytics, Inc. operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing. The company was incorporated in 2008 and is headquartered in Atlanta, Georgia.
About LiveRamp
LiveRamp Holdings, Inc., a technology company, operates a data collaboration platform in the United States, Europe, the Asia-Pacific, and internationally. The company operates LiveRamp Data Collaboration platform enables an organization to unify customer and prospect data to build a single view of the customer in a way that protects consumer privacy. Its platform supports various people-based marketing solutions, including data collaboration, activation, measurement and analytics, identity, and data marketplace. The company sells its solutions to enterprise marketers, agencies, marketing technology providers, publishers, and data providers in various industry verticals, such as financial, insurance and investment services, retail, automotive, telecommunications, high tech, consumer packaged goods, healthcare, travel, entertainment, and non-profit. The company was formerly known as Acxiom Holdings, Inc. and changed its name to LiveRamp Holdings, Inc. in October 2018. The company was incorporated in 2018 and is headquartered in San Francisco, California.
Receive News & Ratings for Cardlytics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardlytics and related companies with MarketBeat.com's FREE daily email newsletter.
